Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 2

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Retinoblastoma 3Stomach Neoplasms 2Pancreatic Neoplasms 2Keratosis, Actinic 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinal Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Osteosarcoma 1Neuroblastoma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Esophageal Neoplasms 1Condylomata Acuminata 1Colorectal Neoplasms 1Colonic Neoplasms 1Appendiceal Neoplasms 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Cryotherapy × Clear all
NCT03524261 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT02230319 2015-10-01

Prevention of Paclitaxel Neuropathy With Cryotherapy

Medical Oncology & Hematology Associates of Northern Virginia

Phase 2 Unknown
39 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡